Search by Drug Name or NDC
NDC 47335-0401-81 YONSA 125 mg/1 Details
YONSA 125 mg/1
YONSA is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is ABIRATERONE ACETATE.
MedlinePlus Drug Summary
Abiraterone is used in combination with prednisone to treat a certain type of prostate cancer that has spread to other parts of the body. Abiraterone is in a class of medications called androgen biosynthesis inhibitors. It works by decreasing the amount of certain hormones in the body.
Related Packages: 47335-0401-81Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Abiraterone
Product Information
NDC | 47335-0401 |
---|---|
Product ID | 47335-401_2bfc9d4d-6445-4228-8fe5-acb108de89db |
Associated GPIs | 21406010200310 |
GCN Sequence Number | 078461 |
GCN Sequence Number Description | abiraterone acet,submicronized TABLET 125 MG ORAL |
HIC3 | V1J |
HIC3 Description | ANTINEOPLASTIC - ANTIANDROGENIC AGENTS |
GCN | 44795 |
HICL Sequence Number | 044946 |
HICL Sequence Number Description | ABIRATERONE ACETATE, SUBMICRONIZED |
Brand/Generic | Brand |
Proprietary Name | YONSA |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | abiraterone acetate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 125 |
Active Ingredient Units | mg/1 |
Substance Name | ABIRATERONE ACETATE |
Labeler Name | Sun Pharmaceutical Industries, Inc. |
Pharmaceutical Class | Cytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA210308 |
Listing Certified Through | 2024-12-31 |
Package
NDC 47335-0401-81 (47335040181)
NDC Package Code | 47335-401-81 |
---|---|
Billing NDC | 47335040181 |
Package | 120 TABLET in 1 BOTTLE, PLASTIC (47335-401-81) |
Marketing Start Date | 2018-05-22 |
NDC Exclude Flag | N |
Pricing Information | N/A |